Filippos Kesisoglou

Filippos Kesisoglou is a Senior Principal Scientist in the Biopharmaceutics and Specialty Dosage Forms group, Pharmaceutical Sciences, Merck Research Laboratories where he has been leading the oral biopharmaceutics and modeling & simulation quantitative biopharmaceutics efforts. His work spans the fields of biopharmaceutics and formulation development, pharmacokinetics, and absorption, PBPK and IVIVC modeling as related to clinical, drug product development and CMC regulatory applications. He has been a key contributor to several new drug applications. He holds a diploma in Pharmacy from Aristotle University of Thessaloniki, Greece and MSc and PhD degrees in Pharmaceutics from University of Michigan. He has authored/co-authored more than 55 manuscripts and more than 70 meeting abstracts/podium presentations in national/international meetings in the fields of biopharmaceutics, PBPK modeling, formulation development and drug delivery. In 2017 he was elected a Fellow of the American Association of Pharmaceutical Scientists (AAPS).